Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotype-driven Chemotherapy in Advanced NSCLC
NCT00736814Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Jun 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, docetaxel, gemcitabine, vinorelbine in non-small cell lung cancer (NSCLC), sponsored by Yonsei University. Status: unknown.
02
Drugs
carboplatindocetaxelgemcitabinevinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00736814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00736814.